ReviewAdvances in experimental medicine and biology2024
Artificial Intelligence in Brain Tumors.
Review in Advances in experimental medicine and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The introduction of "intelligent machines" goes back to Alan Turing in the 1940s. Artificial intelligence (AI) is a broad umbrella covering different methodologies, such as machine learning and deep learning. Deep learning, characterized by multilayered computational models, has revolutionized data representation across various abstraction levels. Deep learning can unravel complex structures within extensive datasets by guiding computer algorithms to adjust internal parameters for successive data representation layers.Specifically, deep convolutional networks have advanced image, video, and audio data analysis, while recurrent networks have offered insights into sequential data, notably in medical imaging. Radiomics involves extraction and quantification of features from medical images and has emerged as an important field of research. Interesting predictions can be made with the help of radiomics features and machine learning algorithms. This chapter reviews the applications of AI methodologies in brain tumors. We highlight the significance of data preprocessing and augmentation and explore deep learning models for brain tumor segmentation and the fusion of clinical and imaging data.
Indexed as
Identifiers
39523267What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.